June 29, 2017 / 11:08 AM / 5 months ago

BRIEF-Valeant pharmaceuticals completes sale of Dendreon to Sanpower Group

June 29 (Reuters) - Sanpower Group Co Ltd

* Valeant pharmaceuticals completes sale of Dendreon to Sanpower Group

* ‍company reiterates its expectation to pay down $5 billion in debt from divestiture proceeds and free cash flow within 18 months of August 2016​

* Estimates that expected revenue and adjusted EBITDA from Dendreon business in second half of 2017 would have been about $170 million and $65 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below